Exchange: NASDAQ·Updated 04:10 PM EDT
News
all
press releases
Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2026
Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2026 Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2026 PR Newswire SALT LAKE CITY, Aug. 4, 2026 SALT LAKE CITY, Aug. 4, 2026 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a specialty...
PR Newswire
More News
Lipocine Appoints Michael J. Grissinger to Board of Directors
Lipocine Appoints Michael J. Grissinger to Board of Directors Lipocine Appoints Michael J. Grissinger to Board of Directors PR Newswire SALT LAKE CITY, Aug. 3, 2026 SALT LAKE CITY, Aug. 3, 2026 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary...
PR Newswire
Lipocine Inc. to Host Virtual KOL Event Highlighting Unmet Needs in Postpartum Depression and the Clinical Profile of LPCN 1154
Lipocine Inc. to Host Virtual KOL Event Highlighting Unmet Needs in Postpartum Depression and the Clinical Profile of LPCN 1154 Lipocine Inc. to Host Virtual KOL Event Highlighting Unmet Needs in Postpartum Depression and the Clinical Profile of LPCN 1154 PR Newswire SALT LAKE CITY, June 4, 2026...
PR Newswire
Lipocine Announces LPCN 1154 Phase 3 Data Accepted for Oral Presentation at 2026 ASCP Annual Meeting
Lipocine Announces LPCN 1154 Phase 3 Data Accepted for Oral Presentation at 2026 ASCP Annual Meeting Lipocine Announces LPCN 1154 Phase 3 Data Accepted for Oral Presentation at 2026 ASCP Annual...
PR Newswire
Lipocine to Present at A.G.P.'s Annual Virtual Healthcare Company Showcase
Lipocine to Present at A.G.P.'s Annual Virtual Healthcare Company Showcase Lipocine to Present at A.G.P.'s Annual Virtual Healthcare Company Showcase PR Newswire SALT LAKE CITY, May 18, 2026 SALT...
PR Newswire
Lipocine Announces Financial Results for the First Quarter Ended March 31, 2026
Lipocine Announces Financial Results for the First Quarter Ended March 31, 2026 Lipocine Announces Financial Results for the First Quarter Ended March 31, 2026 PR Newswire SALT LAKE CITY, May 7, 2026...
PR Newswire
Lipocine (LPCN) Reports Q1 Loss, Beats Revenue Estimates
Lipocine (LPCN) delivered earnings and revenue surprises of -5.88% and +19.40%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
BioCryst Pharmaceuticals (BCRX) Reports Q1 Loss, Beats Revenue Estimates
BioCryst (BCRX) delivered earnings and revenue surprises of -150.00% and +0.06%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Lipocine (NASDAQ:LPCN) Director Buys $81,200.00 in Stock
Lipocine Inc. (NASDAQ:LPCN - Get Free Report) Director John Higuchi bought 40,000 shares of the firm's stock in a transaction dated Tuesday, April 7th. The stock was purchased at an average cost of...
MarketBeat
Mahesh Patel Purchases 25,000 Shares of Lipocine (NASDAQ:LPCN) Stock
Lipocine Inc. (NASDAQ:LPCN - Get Free Report) CEO Mahesh Patel purchased 25,000 shares of Lipocine stock in a transaction that occurred on Monday, April 6th. The shares were bought at an average cost...
MarketBeat

Advertisement|Remove ads.